Population banks: Biomarkers of susceptibility and population identity and their operational substrate is germinal-line DNA from a huge number of healthy donors, representative of a concrete country/region or ethnic cohort. Disease-oriented banks for epidemiology: biomarkers of exposure, using a huge number of samples, usually following a healthy exposed cohort/case–control design. Disease-oriented general biobanks (i.e. tumor banks): biomarkers of disease through prospective and/or retrospective collections of diseased tissues and non-diseased tissues and their derivate (DNA/RNA/proteins), usually associated to clinical data and some-times associated to clinical trials for prognostic, diagnostic and therapeutic purpose.
Managing Biomarker-Driven Clinical Trials Miami, Florida, USA, Genomic Sample Prep and Biomarker Assay Development San Francisco, USA, Cancer Immunotherapy San Francisco, USA, Biomarkers for Cancer Immunotherapy San Francisco, USA, Biomarkers & Diagnostics World Congress Philadelphia, USA, Molecular and Cellular Basis of Growth and Regeneration (A3) Breckenridge, Colorado, USA, Phacilitate Cell & Gene Therapy World Washington D.C., USA, Craniofacial Morphogenesis & Tissue Regeneration Ventura, CA, USA, Keystone Stem Cells and Cancer Breckenbridge, CO, USA, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA.
According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.
Biobanks play a crucial role in biomedical research. The wide array of Biospecimen (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalog specimens using genetic and other traits, such as age, gender, blood type, and ethnicity.
- Impact of Biobanking and Clinical Databases
- Dried Blood Spots: New Applications for Biobanking?
- Tissue Screening, Preparation and Antibiotic Sterilization
- Avoiding of Transplantation rejection
- Forensic Study of Identity
Related Conference of Biobank Applications
Biobank Applications Conference Speakers
- Biobank Applications
- Biobank Ethics
- Biobank in Genomics
- Biobank in Microbiology
- Biobanking Informatics
- Biorepository & Biospecimen
- Brain Banking
- Cryopreservation Methods
- Disease based biobank
- Fertility biobanks
- Germplasm Bank
- Human cancer biobank
- Immune banking
- Market Analysis in Biobanking
- Next Generation Biobanking
- Stem cell Biobank
- Stem cell Biobanking
- Tissue engineering